Mainz Biomed gibt Vereinbarung mit Quest Diagnostics über die Bereitstellung von Labor-Services im Rahmen der klinischen Studie für den Darmkrebsfrüherkennungstest…
Quest Diagnostics stock hits 52-week high at $165.11…
Cautious investors have long known that healthcare spending rises steadily regardless of the direction of the overall economy. Its considered…
…
Investors feel optimistic about Quest Diagnostics strength in Advanced Diagnostics. Robust base business volumes are also encouraging.…
Geschäftstreiber: Quest Diagnostics (DGX) gehört zu den weltweit führenden Anbietern im Bereich klinischer Test- und Diagnostik-Verfahren rund um verschiedene Segmente.…
Quest Diagnostics stock hits 52-week high of $159.46…
…
Quest Diagnostics third-quarter 2024 performance reflects impressive DIS business growth and the benefits of new acquisitions.…
…
Quest Diagnostics is expected to deliver robust base business growth in the third quarter of 2024.…
A key driver in Brain Health growth is Quest Diagnostics Alzheimers disease portfolio, featuring the AD-Detect blood testing services and…
Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.…
With the completion of the acquisition, Allina Healths clinic physicians will now have access to Quest Diagnostics laboratory services.…
When you buy and hold a stock for the long term, you definitely want it to provide a positive return.…
BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) is pleased to announce that it has established a North Carolina,…
DGX acquires 100% of LifeLabs from OMERS, at approximately $1 billion. It will help LifeLabs to improve healthcare for Canadians.…
Quest Diagnostics (DGX) signs an agreement to acquire select assets of University Hospitals outreach laboratory services business.…
Quest Diagnostics (DGX) introduces 13 blood tests to identify micronutrient deficiencies.…
Quest Diagnostics (DGX) joint study with the University of Alabama finds pregnant women undertested for STIs, raising serious concerns on…
Quest Diagnostics stock hits 52-week high at $151.94…
A key driver in Brain Health growth is Quest Diagnostics (DGX) Alzheimers disease portfolio, featuring the AD-Detect blood testing services…
Quest Diagnostics (DGX) robust base business performance instills optimism for long-term growth.…
Quest Diagnostics (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.…
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.73% and 0.50%, respectively, for the quarter ended June 2024. Do…
…
Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However,…
…
The Global Precision Diagnostics Market Size was Valued at USD 74.98 Billion in 2023 and the Worldwide Precision Diagnostics Market…
By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for…
The Global PCOS Diagnostic Market Size was Valued at USD 3.68 Billion in 2023 and the Worldwide PCOS Diagnostic Market…
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues…
DJ PTA-News: Small- & MicroCap Investment: KI als Wachstumsmotor: CrowdStrike, Adcore, Quest Diagnostics Unternehmensmitteilung für den Kapitalmarkt Frankfurt (pta/23.06.2024/10:00) -…
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share…
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer…
…
…
Wenig Kursbewegung aktuell bei der Aktie von Quest Diagnostics . Der jüngste Kurs betrug 136,84 US-Dollar. Die Wertschätzung der Börsenteilnehmer…
…
Quest Diagnostics (DGX) pathology laboratories nationwide are set to get a boost with PathAIs AISight digital pathology image management system.…
Quest Diagnostics (DGX) latest transaction combines its oncology expertise and scale with PathAIs AI and digital pathology innovations.…
Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.…
CODE Das Wertpapier notiert aktuell bei 128,30 US-Dollar. Kaum auffällig ist derzeit an der Börse der Kurs von Quest Diagnostics.…
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics (DGX) base business performance in the first quarter…
Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal…
…
Quest Diagnostics (DGX) faces intense competition, primarily from LabCorp as well as other commercial laboratories and hospitals.…
Quest Diagnostics (DGX) debuts the MelaNodal Predict test in collaboration with SkylineDx.…
Quest Diagnostics (DGX) introduces the first consumer-initiated blood test with physician consult on questhealth.com.…
Strength of the base business bodes well for Quest Diagnostics (DGX).…